AGP Executive Report

Last update: 10 hours ago

Reproductive Health: Liechtenstein’s Prince Alois vetoed a bill to liberalise abortion, saying it did not adequately protect unborn life. It is the first time he has used his absolute veto, leaving campaigners frustrated after parliament passed the measure. Cancer Treatment: The European Medicines Agency’s CHMP recommended approval of RASONQUE for adults with metastatic pancreatic cancer who have had prior treatment. The EU decision is still pending; in a phase 3 trial, the drug reduced the risk of death compared with chemotherapy.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Sep. 7, 2026

Swiss parabolic flight campaign pivots toward commercial space applications

AGP

fallback image
Jul. 3, 2026

European Commission authorizes CinnaGen’s osteoporosis biosimilar Zandoriah in EU

AGP

fallback image
Jul. 28, 2026

The European releases its Summer 2026 edition

AGP

fallback image
Jul. 2, 2026

American Swiss Foundation honors Adrian Keller at leadership dinner in Rüschlikon

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Biosimilar Uptake in Europe Reached 40.7%, With Wide Country Gaps

Biosimilar Uptake in Europe Reached 40.7%, With Wide Country Gaps

Section 232 Pharmaceutical Tariffs Are Now in Effect: It’s Not Too Late to Consider Duty-Mitigation Strategies

Section 232 Pharmaceutical Tariffs Are Now in Effect: It’s Not Too Late to Consider Duty-Mitigation Strategies


fallback image
Oct. 15, 2026

Revolution Medicines’ RASONQUE(™) (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer

GlobeNewswire, Inc.

fallback image
Sep. 25, 2026

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

GlobeNewswire, Inc.

fallback image
Oct. 21, 2026

Five Nobel Laureates Gather in Singapore as Nobel Heroes & AI4SCI Summit 2026 Concludes

EIN Presswire

fallback image
Sep. 18, 2026

Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

GlobeNewswire, Inc.

fallback image
Jul. 23, 2026

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Cost of Living Unrest Fuels the Rise of Europe's Far-Right
Play
Cost of Living Unrest Fuels the Rise of Europe's Far-Right
YouTube video thumbnail: Protests in France, Italy, Spain, Portugal and Albania Are Setting Europe's Streets Ablaze
Play
Protests in France, Italy, Spain, Portugal and Albania Are Setting Europe's Streets Ablaze
YouTube video thumbnail: Discover Affinity Group Publishing
Play
Discover Affinity Group Publishing
YouTube video thumbnail: Europe Joins the Global Race for Arctic Power and Resources
Play
Europe Joins the Global Race for Arctic Power and Resources
YouTube video thumbnail: Europe’s Satellite Push Raises US Concerns
Play
Europe’s Satellite Push Raises US Concerns

Video Title

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.